Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 1
2007 3
2008 3
2009 3
2010 1
2011 1
2012 4
2013 3
2014 1
2015 1
2016 2
2017 2
2018 4
2019 3
2021 2
2022 2
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
CFC1 is a cancer stemness-regulating factor in neuroblastoma.
Chikaraishi K, Takenobu H, Sugino RP, Mukae K, Akter J, Haruta M, Kurosumi M, Endo TA, Koseki H, Shimojo N, Ohira M, Kamijo T. Chikaraishi K, et al. Among authors: haruta m. Oncotarget. 2017 Jul 11;8(28):45046-45059. doi: 10.18632/oncotarget.18464. Oncotarget. 2017. PMID: 28620148 Free PMC article.
EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
Li Z, Takenobu H, Setyawati AN, Akita N, Haruta M, Satoh S, Shinno Y, Chikaraishi K, Mukae K, Akter J, Sugino RP, Nakazawa A, Nakagawara A, Aburatani H, Ohira M, Kamijo T. Li Z, et al. Among authors: haruta m. Oncogene. 2018 May;37(20):2714-2727. doi: 10.1038/s41388-018-0133-3. Epub 2018 Mar 6. Oncogene. 2018. PMID: 29507419 Free PMC article.
Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
Koshinaga T, Takimoto T, Okita H, Tanaka Y, Inoue E, Oue T, Nozaki M, Tsuchiya K, Haruta M, Kaneko Y, Fukuzawa M. Koshinaga T, et al. Among authors: haruta m. Pediatr Int. 2019 Apr;61(4):351-357. doi: 10.1111/ped.13811. Epub 2019 Apr 16. Pediatr Int. 2019. PMID: 30786111 Clinical Trial.
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma.
Kurashina R, Ando K, Inoue M, Maruyama R, Mitani K, Takenobu H, Haruta M, Onuki R, Matsuoka Y, Kamijo T, Kageyama Y. Kurashina R, et al. Among authors: haruta m. Cancer Diagn Progn. 2023 Mar 3;3(2):230-235. doi: 10.21873/cdp.10206. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875313 Free PMC article.
Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma.
Ando K, Kurashina R, Motoi N, Iizuka T, Inoue M, Maruyama R, Mitani K, Takenobu H, Haruta M, Onuki R, Matsuoka Y, Kamijo T, Kageyama Y. Ando K, et al. Among authors: haruta m. Biochem Biophys Res Commun. 2023 Oct 8;676:165-170. doi: 10.1016/j.bbrc.2023.07.054. Epub 2023 Jul 26. Biochem Biophys Res Commun. 2023. PMID: 37517219 Free article.
40 results